Cardiovascular Considerations In Antipsychotic Use: An Editorial
Cardiovascular Considerations In Antipsychotic Use: An Editorial
Abstract
No Abstract No Abstract No Abstract
1] Gnanavel S, Hussain S. Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland. World J Psychiatry. 2018;8(1):27-32. https://doi.org/10.5498/wjp.v8.i1.27
[2] Li XQ, Tang XR, Li LL. Antipsychotics cardiotoxicity: What’s known and what’s next. World J Psychiatry. 2021;11(10):736- 53. https://doi.org/10.5498/wjp.v11.i10.736
[3] Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360(3):225-35. https://doi.org/10.1056/NEJMoa0806994
[4] Gopal S, Hough D, Karcher K, Nuamah I, Palumbo J, Berlin JA, et al. Risk of cardiovascular morbidity with risperidone or paliperidone treatment: analysis of 64 randomized, double-blind trials. J Clin Psychopharmacol. 2013;33(2):157-61. https://doi. org/10.1097/JCP.0b013e318283983f
[5] Bishara D, Taylor D. Adverse effects of clozapine in older patients: epidemiology, prevention and management. Drugs
Aging. 2014;31(1):11-20. https://doi.org/10.1007/s40266- 013-0144-2
[6] Muench J, Hamer AM. Adverse effects of antipsychotic medications. Am Fam Physician. 2010;81(5):617-22.
[7] Gugger JJ. Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management. CNS Drugs. 2011;25(8):659-71 https://doi.org/10.2165/11591710-00000 0000-00000
[8] Woo YS, Kim W, Chae JH, Yoon BH, Bahk WM. Blood pressure
[9] Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003;89(11):1363-72. https://doi. org/10.1136/heart.89.11.1363
[10]Ye X, Shi C, Shen YW, Zhao ZQ, Jiang Y, Li LL. Forensic Analysis of 24 Cases of Long-term Antipsychotics Use-Induced Sudden Unexpected Deaths. Fa Yi Xue Za Zhi. 2018;34(6):644-7.
[11]Young CR, Bowers MB Jr, Mazure CM. Management of the adverse effects of clozapine. Schizophr Bull. 1998;24(3):381-90. https://doi.org/10.1093/oxfordjournals.schbul.a033333
[12]Horacek J, Bubenikova-Valesova V, Kopecek M, Palenicek T, Dockery C, Mohr P, et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs. 2006;20(5):389-409. https://doi. org/10.2165/00023210-200620050-00004
[13]Zhu J, Hou W, Xu Y, Ji F, Wang G, Chen C, et al. Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps. Psychiatry Res. 2019;281:112598. https://doi.org/10.1016/j. psychres.2019.112598
[14]Li L, Dong X, Tu C, Li X, Peng Z, Zhou Y, et al. Opposite effects of cannabinoid CB(1) and CB(2) receptors on antipsychotic clozapine-induced cardiotoxicity. Br J Pharmacol. 2019;176(7):890-905. https://doi.org/10.1111/bph.14591
[15]Orsolini L, De Berardis D, Volpe U. Up-to-date expert opinion on the safety of recently developed antipsychotics. Expert Opin Drug Saf. 2020;19(8):981-98. https://doi.org/10.1080/1 4740338.2020.1795126
[2] Li XQ, Tang XR, Li LL. Antipsychotics cardiotoxicity: What’s known and what’s next. World J Psychiatry. 2021;11(10):736- 53. https://doi.org/10.5498/wjp.v11.i10.736
[3] Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360(3):225-35. https://doi.org/10.1056/NEJMoa0806994
[4] Gopal S, Hough D, Karcher K, Nuamah I, Palumbo J, Berlin JA, et al. Risk of cardiovascular morbidity with risperidone or paliperidone treatment: analysis of 64 randomized, double-blind trials. J Clin Psychopharmacol. 2013;33(2):157-61. https://doi. org/10.1097/JCP.0b013e318283983f
[5] Bishara D, Taylor D. Adverse effects of clozapine in older patients: epidemiology, prevention and management. Drugs
Aging. 2014;31(1):11-20. https://doi.org/10.1007/s40266- 013-0144-2
[6] Muench J, Hamer AM. Adverse effects of antipsychotic medications. Am Fam Physician. 2010;81(5):617-22.
[7] Gugger JJ. Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management. CNS Drugs. 2011;25(8):659-71 https://doi.org/10.2165/11591710-00000 0000-00000
[8] Woo YS, Kim W, Chae JH, Yoon BH, Bahk WM. Blood pressure
[9] Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003;89(11):1363-72. https://doi. org/10.1136/heart.89.11.1363
[10]Ye X, Shi C, Shen YW, Zhao ZQ, Jiang Y, Li LL. Forensic Analysis of 24 Cases of Long-term Antipsychotics Use-Induced Sudden Unexpected Deaths. Fa Yi Xue Za Zhi. 2018;34(6):644-7.
[11]Young CR, Bowers MB Jr, Mazure CM. Management of the adverse effects of clozapine. Schizophr Bull. 1998;24(3):381-90. https://doi.org/10.1093/oxfordjournals.schbul.a033333
[12]Horacek J, Bubenikova-Valesova V, Kopecek M, Palenicek T, Dockery C, Mohr P, et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs. 2006;20(5):389-409. https://doi. org/10.2165/00023210-200620050-00004
[13]Zhu J, Hou W, Xu Y, Ji F, Wang G, Chen C, et al. Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps. Psychiatry Res. 2019;281:112598. https://doi.org/10.1016/j. psychres.2019.112598
[14]Li L, Dong X, Tu C, Li X, Peng Z, Zhou Y, et al. Opposite effects of cannabinoid CB(1) and CB(2) receptors on antipsychotic clozapine-induced cardiotoxicity. Br J Pharmacol. 2019;176(7):890-905. https://doi.org/10.1111/bph.14591
[15]Orsolini L, De Berardis D, Volpe U. Up-to-date expert opinion on the safety of recently developed antipsychotics. Expert Opin Drug Saf. 2020;19(8):981-98. https://doi.org/10.1080/1 4740338.2020.1795126
| Files | ||
| Issue | Vol 8 No 3 (2023): May-June | |
| Section | Editorial | |
| DOI | https://doi.org/10.18502/crcp.v8i3.14229 | |
| Keywords | ||
| No Keyword No Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Hasanzadeh A, Nateghi S. Cardiovascular Considerations In Antipsychotic Use: An Editorial. CRCP. 2023;8(3):91-93.
